ES382429A1 - Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos. - Google Patents

Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos.

Info

Publication number
ES382429A1
ES382429A1 ES382429A ES382429A ES382429A1 ES 382429 A1 ES382429 A1 ES 382429A1 ES 382429 A ES382429 A ES 382429A ES 382429 A ES382429 A ES 382429A ES 382429 A1 ES382429 A1 ES 382429A1
Authority
ES
Spain
Prior art keywords
radical
radicals
lower alcohol
optionally substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES382429A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES382429A1 publication Critical patent/ES382429A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20Hydroxy-styrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
ES382429A 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos. Expired ES382429A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (de) 1969-08-05 1969-08-05 ß-Aryl-2-aminoalkoxy-styrole und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES382429A1 true ES382429A1 (es) 1972-11-16

Family

ID=5741970

Family Applications (6)

Application Number Title Priority Date Filing Date
ES382428A Expired ES382428A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiextirenos.
ES382427A Expired ES382427A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos.
ES382430A Expired ES382430A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta-aril-2-a- minoalcoxiestirenoss.
ES382429A Expired ES382429A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos.
ES382425A Expired ES382425A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 -aminoalcoiestirenos.
ES382426A Expired ES382426A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 -aminoalcoxiestiernos.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES382428A Expired ES382428A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiextirenos.
ES382427A Expired ES382427A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos.
ES382430A Expired ES382430A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta-aril-2-a- minoalcoxiestirenoss.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES382425A Expired ES382425A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 -aminoalcoiestirenos.
ES382426A Expired ES382426A1 (es) 1969-08-05 1970-08-04 Procedimiento para la preparacion de nuevos beta - aril - 2 -aminoalcoxiestiernos.

Country Status (25)

Country Link
JP (6) JPS4941433B1 (ja)
KR (1) KR780000113B1 (ja)
AT (5) AT301565B (ja)
BE (1) BE754405A (ja)
BG (6) BG17951A3 (ja)
CH (6) CH548367A (ja)
CS (6) CS170533B2 (ja)
DE (1) DE1939809B2 (ja)
DK (1) DK139717B (ja)
ES (6) ES382428A1 (ja)
FI (1) FI54912C (ja)
FR (1) FR2068463B1 (ja)
GB (1) GB1307436A (ja)
HU (1) HU163185B (ja)
IE (1) IE34634B1 (ja)
IL (1) IL35047A (ja)
NL (1) NL7011590A (ja)
NO (1) NO135243C (ja)
PH (1) PH9520A (ja)
PL (2) PL93130B1 (ja)
RO (5) RO57794A (ja)
SE (1) SE382211B (ja)
SU (5) SU439965A3 (ja)
YU (2) YU198170A (ja)
ZA (1) ZA705411B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (ja) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (ja) * 1978-03-09 1985-10-11 三菱化学株式会社 ω−アミノアルコキシスチルベン類及びその酸付加塩
DE2818765A1 (de) 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE2818998A1 (de) * 1978-04-29 1979-11-15 Basf Ag 3-alkyl-5-(2-hydroxy-styryl)-isoxazole und verfahren zu ihrer herstellung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE2943405A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5874379U (ja) * 1981-11-16 1983-05-19 富士通株式会社 電子装置
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
PL3284449T3 (pl) 2011-06-10 2020-03-31 The Procter & Gamble Company Pielucha jednorazowego użytku
CN103596535B (zh) 2011-06-10 2015-11-25 宝洁公司 用于一次性吸收制品的吸收芯
JP6339010B2 (ja) 2011-06-10 2018-06-06 ザ プロクター アンド ギャンブル カンパニー 吸収性物品の吸収性構造体
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
ES2655690T3 (es) 2013-06-14 2018-02-21 The Procter & Gamble Company Artículo absorbente y canales de formación de núcleo absorbente cuando están húmedos
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (en) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbent cores having material free areas
PL2886092T3 (pl) 2013-12-19 2017-03-31 The Procter And Gamble Company Wkłady chłonne z obszarami tworzącymi kanały i zgrzewami osłony c

Also Published As

Publication number Publication date
DE1939809B2 (de) 1978-04-13
DK139717C (ja) 1979-09-17
RO58837A (ja) 1975-09-15
CH548368A (de) 1974-04-30
BG17950A3 (ja) 1974-03-05
CH548981A (de) 1974-05-15
FI54912C (fi) 1979-04-10
ES382427A1 (es) 1972-11-16
CH548983A (de) 1974-05-15
CH548367A (de) 1974-04-30
ZA705411B (en) 1971-05-27
CS170537B2 (ja) 1976-08-27
JPS5113149B1 (ja) 1976-04-26
BG17951A3 (ja) 1974-03-05
CS170534B2 (ja) 1976-08-27
BG20095A3 (ja) 1975-10-30
CS170538B2 (ja) 1976-08-27
BG18599A3 (ja) 1975-02-25
IE34634L (en) 1971-02-05
JPS5113146B1 (ja) 1976-04-26
FI54912B (fi) 1978-12-29
SU450398A3 (ru) 1974-11-15
CS170533B2 (ja) 1976-08-27
IL35047A (en) 1973-05-31
PL93130B1 (ja) 1977-05-30
YU37478A (en) 1979-07-10
YU198170A (en) 1979-07-10
CS170536B2 (ja) 1976-08-27
PH9520A (en) 1976-01-09
ES382426A1 (es) 1972-11-16
HU163185B (ja) 1973-06-28
AT302346B (de) 1972-10-10
BE754405A (fr) 1971-02-04
ES382430A1 (es) 1972-12-01
NO135243C (ja) 1977-03-09
BG17952A3 (ja) 1974-03-05
BG18600A3 (ja) 1975-02-25
IL35047A0 (en) 1970-10-30
JPS5113150B1 (ja) 1976-04-26
KR780000113B1 (en) 1978-04-15
DE1939809C3 (ja) 1979-01-11
AT302345B (de) 1972-10-10
CS170535B2 (ja) 1976-08-27
JPS5113148B1 (ja) 1976-04-26
DE1939809A1 (de) 1971-02-18
CH548982A (de) 1974-05-15
SU432712A3 (ja) 1974-06-15
GB1307436A (en) 1973-02-21
AT303055B (de) 1972-11-10
JPS4941433B1 (ja) 1974-11-08
AT301565B (de) 1972-09-11
RO57794A (ja) 1975-06-15
NO135243B (ja) 1976-11-29
RO57548A (ja) 1975-02-15
SU428597A3 (ru) 1974-05-15
ES382425A1 (es) 1972-11-16
FR2068463A1 (ja) 1971-08-27
CH548366A (de) 1974-04-30
JPS5113147B1 (ja) 1976-04-26
RO58861A2 (ro) 1975-06-30
RO57793A (ja) 1975-03-15
AT302344B (de) 1972-10-10
SU439965A3 (ru) 1974-08-15
SU439966A3 (ru) 1974-08-15
FR2068463B1 (ja) 1974-08-30
PL78370B1 (ja) 1975-06-30
SE382211B (sv) 1976-01-19
DK139717B (da) 1979-04-02
ES382428A1 (es) 1972-11-16
IE34634B1 (en) 1975-07-09
NL7011590A (ja) 1971-02-09

Similar Documents

Publication Publication Date Title
ES382429A1 (es) Procedimiento para la preparacion de nuevos beta - aril - 2 - aminoalcoxiestirenos.
ES411804A1 (es) Procedimiento para la obtencion de derivados de quinoxalinay quinazolina.
ES440760A1 (es) Procedimiento para preparar derivados de quinoxalina y qui- nazolina.
ES411341A1 (es) Procedimiento para la preparacion de compuestos heteroci- clicos sustituidos por un radical guanidinilideno.
ES447063A1 (es) Procedimiento para la produccion de pirazolas-(5) 1-susti- tuidas.
ES320729A1 (es) Procedimiento para la sintesis de nuevos derivados de acido antranilico.
ES391066A1 (es) Procedimiento para la obtencion de derivados del acido al- fa-cianacrilico.
ES434546A1 (es) Procedimiento para la obtencion de 2-amino-6-dialquil-amino-dihidropiridinas.
ES331643A1 (es) Procedimiento para la preparacion de derivados del 1-fenilciclohexano.
ES312240A1 (es) Un proceso para producir una 5-(ariloximetil)-2-oxazolidinationa.
ES297620A1 (es) Procedimiento de obtención de derivados de ácido fenoxiacético
ES392848A1 (es) Un procedimiento para la preparacion de nuevos derivados de indenopirrol.
ES433132A1 (es) Procedimiento para la obtencion de derivados de 1-fenoxi-3- amino-propan-2-ol.
ES394727A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolino-pirimidona-5.
ES401908A1 (es) Procedimiento para preparar compuestos utiles como agentes antidepresivos.
ES396175A1 (es) Procedimiento para la preparacion de compuestos derivados de aminoetanol.
ES303109A1 (es) Procedimiento para la preparacion de imidazo quinazolinas y pirimido quinazolinas.
ES446130A1 (es) Un procedimiento para la preparacion de nuevos derivados de acido 2-alquil (inferior)-2 o 3-cefem-4-carboxilico.
ES396415A1 (es) Un procedimiento para la preparacion de poliarilimidazolas.
ES405106A1 (es) Un procedimiento para la preparacion de un compuesto sele- ccionado entre el grupo formado por una 2-imino-pirrolidina.
ES455963A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4).
ES278128A2 (es) Procedimiento para la preparacion de compuestos heterociclicos sustituidos con una base
ES298298A1 (es) Procedimiento para la preparación de nuevos compuestos heterocíclicos
ES376034A1 (es) Procedimiento para la preparacion de nuevos compuestos qui-micos utilizables como medicamentos de accion psicotropa.
ES421262A1 (es) Un procedimiento para la preparacion de un 2-aminoalcohil-3-fenil-indol.